Locally Advanced Hypopharyngeal Squamous Cell Carcinoma: Clinical Trials

1 trial for Locally Advanced Hypopharyngeal Squamous Cell Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Locally Advanced Hypopharyngeal Squamous Cell Carcinoma: new trials by email Literature Review of Locally Advanced Hypopharyngeal Squamous Cell Carcinoma trials Research Report on Locally Advanced Hypopharyngeal Squamous Cell Carcinoma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With Cisplatin
Cisplatin, Hearing Handicap Inventory for Adults - Screening, Radiation Therapy - Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Phase 2CompletedHyunseok Kang, MD162020-10-142024-06-28

Narrower conditions

Carcinoma (1)  ·  Hypopharyngeal Neoplasms (1)  ·  Laryngeal Neoplasms (1)  ·  Mouth Neoplasms (1)  ·  Oropharyngeal Neoplasms (1)

Broader conditions

Head and Neck Neoplasms (1)  ·  Laryngeal Diseases (1)  ·  Mouth Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Otorhinolaryngologic Diseases (1)  ·  Otorhinolaryngologic Neoplasms (1)  ·  Pharyngeal Diseases (1)  ·  Pharyngeal Neoplasms (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Neoplasms (1)  ·  Stomatognathic Diseases (1)

Interventions

1,2-diaminocyclohexaneplatinum II citrate (1)  ·  Cisplatin (1)  ·  Radiation (1)  ·  Radiotherapy (1)  ·  sodium thiosulfate (1)

Sponsors

Hyunseok Kang, MD (1)

Countries

United States (1)

Top investigators

Hyunseok Kang, MD (1)